For the Inventor, By the Inventor

Enter assignee name

Fondation Imagine

USPTO Granted Patents = 15

% Expired Patents = 20.0

EPO Patents = 17

Forward Citations = 4

Loading Chart...

Loading Chart...

59 inventors (with patents filed for the assignee):

Olivier Hermine (7 out of 15 patents)

Flavia Guillem (3 out of 3 patents)

Jean-Benoit Arlet (3 out of 3 patents)

4. Laurence Legeai-Mallet (2 out of 4 patents)

5. Arnold Munnich (2 out of 12 patents)

6. Zakia Belaid-Choucair (2 out of 2 patents)

7. Carmen Garrido-Fleury (2 out of 3 patents)

8. Renaud Seigneuric (2 out of 3 patents)

9. Genevieve Courtois (2 out of 2 patents)

10. Antonio Segura Carretero (2 out of 2 patents)

11. Maria De La Luz Cadiz Gurrea (2 out of 2 patents)

12. Leila Maouche-Chretien (1 out of 1 patent)

13. Christine Bodemer (1 out of 2 patents)

14. Laura Polivka (1 out of 1 patent)

15. David Bikard (1 out of 21 patents)

15 patents: Sort by Forward Citations

1. 12668812 - RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME (2026-06-30),

2. 12257232 - Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias (2025-03-25),

3. 11951090 - Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias (2024-04-09),

4. 11857532 - Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxia (2024-01-02),

5. 11725183 - Method of culturing segmented filamentous bacteria in vitro (2023-08-15),

6. 11667913 - Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof (2023-06-06),

7. 11629192 - Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway (2023-04-18),

8. 11389434 - Methods and pharmaceutical compositions for the treatment of mast cell diseases (2022-07-19),

9. 11065230 - Methods and pharmaceutical compositions for the treatment of systemic mastocytosis (2021-07-20),

10. 10653687 - Methods and pharmaceutical compostions for treating rhabdomyolysis (2020-05-19),

11. 10647752 - Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1 (2020-05-12),

12. 10435665 - Method of culturing segmented filamentous bacteria in vitro (2019-10-08),

13. 9861615 - Methods and pharmaceutical compositions for the treatment of beta-thalassemias (2018-01-09),

14. 9675590 - Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes (2017-06-13),

15. 9377471 - Methods and compositions for the treatment of β-thalassemia (2016-06-28),

Fondation Imagine is a non-profit medical research institute based in Paris, France. Their mission is to advance understanding and treatment of genetic diseases by conducting world-class research, providing advanced healthcare, and educating the next generation of scientists and healthcare professionals.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#284 in Paris

#1,257 in France

#39,846 in the World

Fondation Imagine

Forward Citations = 4

59 inventors:

Olivier Hermine (7 out of 15 patents)

Flavia Guillem (3 out of 3 patents)

Jean-Benoit Arlet (3 out of 3 patents)

4. Laurence Legeai-Mallet (2 out of 4 patents)

5. Arnold Munnich (2 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…